statistiche ricercatore

RUBINO, TIZIANA

Distribuzione geografica

Continente	#
NA - Nord America	13.391
EU - Europa	6.666
AS - Asia	3.831
SA - Sud America	514
Continente sconosciuto - Info sul continente non disponibili	175
AF - Africa	68
OC - Oceania	6
Totale	24.651

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	13.119
IT - Italia	3.527
SG - Singapore	1.335
UA - Ucraina	927
CN - Cina	761
SE - Svezia	568
VN - Vietnam	549
TR - Turchia	453
HK - Hong Kong	430
BR - Brasile	429
DE - Germania	286
FI - Finlandia	265
GB - Regno Unito	254
IE - Irlanda	243
FR - Francia	209
CA - Canada	140
RU - Federazione Russa	134
IN - India	68
NL - Olanda	63
MX - Messico	59
BD - Bangladesh	52
JP - Giappone	51
PL - Polonia	32
BE - Belgio	28
AR - Argentina	26
CZ - Repubblica Ceca	26
ES - Italia	25
ZA - Sudafrica	24
IQ - Iraq	22
NG - Nigeria	15
CO - Colombia	13
PK - Pakistan	13
CL - Cile	11
CR - Costa Rica	11
EU - Europa	11
CH - Svizzera	10
GT - Guatemala	9
MD - Moldavia	9
VE - Venezuela	9
AT - Austria	8
NP - Nepal	8
SA - Arabia Saudita	8
TT - Trinidad e Tobago	8
UZ - Uzbekistan	8
HN - Honduras	7
MY - Malesia	7
NI - Nicaragua	7
PH - Filippine	7
BG - Bulgaria	6
EC - Ecuador	6
JM - Giamaica	6
JO - Giordania	6
KR - Corea	6
LT - Lituania	6
MA - Marocco	6
AE - Emirati Arabi Uniti	5
AU - Australia	5
BO - Bolivia	5
DO - Repubblica Dominicana	5
GP - Guadalupe	5
ID - Indonesia	5
IL - Israele	5
KE - Kenya	5
KZ - Kazakistan	5
PE - Perù	5
PR - Porto Rico	5
PT - Portogallo	5
PY - Paraguay	5
DK - Danimarca	4
DZ - Algeria	4
HU - Ungheria	4
RO - Romania	4
TN - Tunisia	4
AL - Albania	3
AZ - Azerbaigian	3
EE - Estonia	3
EG - Egitto	3
NO - Norvegia	3
PA - Panama	3
PS - Palestinian Territory	3
SK - Slovacchia (Repubblica Slovacca)	3
TH - Thailandia	3
TW - Taiwan	3
UY - Uruguay	3
BA - Bosnia-Erzegovina	2
BS - Bahamas	2
CW - ???statistics.table.value.countryCode.CW???	2
HR - Croazia	2
HT - Haiti	2
IR - Iran	2
LB - Libano	2
OM - Oman	2
SM - San Marino	2
SN - Senegal	2
SV - El Salvador	2
AM - Armenia	1
AO - Angola	1
BB - Barbados	1
BH - Bahrain	1
CI - Costa d'Avorio	1
Totale	24.471

Salva come PNG Salva come JPEG

Città	#
Milan	2.050
Fairfield	1.355
Ashburn	1.164
San Jose	1.004
Woodbridge	851
Chandler	755
Singapore	742
Jacksonville	713
Houston	681
Seattle	588
Ann Arbor	534
Wilmington	511
Cambridge	469
Hong Kong	422
Council Bluffs	384
Dearborn	272
Princeton	259
Nyköping	248
Dublin	242
Beijing	231
Dallas	226
Izmir	222
The Dalles	210
New York	193
Boardman	180
Como	177
Rome	173
Chicago	148
Dong Ket	142
Lauterbourg	120
Los Angeles	115
San Mateo	95
Santa Clara	88
Ho Chi Minh City	82
San Diego	72
Hanoi	68
London	57
São Paulo	54
Toronto	52
Tokyo	47
Ogden	44
Varese	42
Helsinki	41
Orem	40
Washington	40
Mexico City	39
Munich	39
Norwalk	32
Warsaw	32
Atlanta	28
Hefei	28
Guangzhou	26
Brooklyn	25
Brussels	25
Brno	24
Montreal	24
San Francisco	24
Chennai	23
Naples	23
Denver	22
Kunming	22
Nanjing	22
Phoenix	22
Ponte Lambro	22
Buffalo	20
Turin	20
Verona	19
Frankfurt am Main	18
Mcallen	17
Manchester	16
Shanghai	16
Kocaeli	15
Poplar	15
Carbonara Al Ticino	14
Johannesburg	14
Nanchang	14
Stockholm	14
Amsterdam	13
Berlin	13
Bologna	13
Cagliari	12
Da Nang	12
Mumbai	12
Nuremberg	12
Redwood City	12
Shenzhen	12
Abuja	11
Jinan	11
Las Vegas	11
Paris	11
Rio de Janeiro	11
Ankara	10
Boston	10
Brescia	10
Brasília	9
Calgary	9
Düsseldorf	9
Longone al Segrino	9
Memphis	9
Miami	9
Totale	17.167

Salva come PNG Salva come JPEG

Nome	#
Cannabinoidi ed ansia: meccanismi cellulari/molecolari e ruolo degli endocannabinoidi nella modulazione degli stati ansiosi	453
Binding of Δ9-tetrahydrocannabinol and diazepam to human serum albumin	409
Correlati cellulari e molecolari dell'abuso di Salvia divinorum: ruolo dei recettori cannabici e k oppioidi	337
Adolescent exposure to THC in female rats disrupts developmental changes in the prefrontal cortex	329
Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta-9-tetrahydrocannabinol exposure in rats	297
Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87-MG and T98G Glioma Cells through a Multitarget Effect	296
Adolescent THC exposure in female rats leads to cognitive deficits through a mechanism involving chromatin modifications in the prefrontal cortex	291
Cannabidivarin completely rescues cognitive deficits and delays neurological and motor defects in male Mecp2 mutant mice	285
Assay of GTPγS binding in autoradiography	274
Bidirectional regulation of mu-opioid and CB1-cannabinoid receptor in rats self-administering heroin or WIN 55,212-2	271
Adolescent exposure to cannabis as a risk factor for psychiatric disorders	268
A molecular basis of analgesic tolerance to cannabinoids	266
Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine	261
The Depressive Phenotype Induced in Adult Female Rats by Adolescent Exposure to THC is Associated with Cognitive Impairment and Altered Neuroplasticity in the Prefrontal Cortex	258
CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour	249
Transcriptomic and Proteomic Analyses of Mouse Cerebellum Reveals Alterations in RasGRF1 Expression Following In Vivo Chronic Treatment with Delta 9-Tetrahydrocannabinol.	247
Long-term hippocampal glutamate synapse and astrocyte dysfunctions underlying the altered phenotype induced by adolescent THC treatment in male rats.	241
Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism	238
Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex	232
Cannabidivarin Treatment Ameliorates Autism-Like Behaviors and Restores Hippocampal Endocannabinoid System and Glia Alterations Induced by Prenatal Valproic Acid Exposure in Rats	232
Chronic Delta(9)-THC Exposure Differently Affects Histone Modifications in the Adolescent and Adult Rat Brain	228
New vistas on cannabis use disorder	226
Long lasting consequences of cannabis exposure in adolescence.	224
Cannabis abuse in adolescence and the risk of psychosis: A brief review of the preclinical evidence.	224
Adult Cellular Neuroadaptations Induced by Adolescent THC Exposure in Female Rats Are Rescued by Enhancing Anandamide Signaling	220
Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine	219
Uso di Cannabis in adolescenza come fattore di rischio per malattie psichiatriche e dipendenza da altre sostanze	218
Cannabinoids and opioids share cAMP pathway in rat splenocytes	216
Endocannabinoids and Mental Disorders.	216
Chronic URB597 treatment at adulthood reverted most depressive-like symptoms induced by adolescent exposure to THC in female rats.	215
Chronic treatment with polychlorinated biphenyls (PCB) during pregnancy and lactation in the rat Part 1: Effects on somatic growth, growth hormone-axis activity and bone mass in the offspring	211
The anabolic steroid nandrolone alters cannabinoid self-administration and brain CB1 receptor density and function	211
Role of endocannabinoids in regulating drug dependence	209
Comparative analysis of molecular strategies attenuating positional effects in lentiviral vectors carrying multiple genes	207
Gender-dependent behavioral and biochemical effects of adolescent delta-9-tetrahydrocannabinol in adult maternally deprived rats.	207
Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids.	206
Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models	206
Chronic FAAH inhibition during nicotine abstinence alters habenular CB1 receptor activity and precipitates depressive-like behaviors.	206
Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain	204
Mice heterozygous for the oxytocin receptor gene (Oxtr(+/-) ) show impaired social behaviour but not increased aggression or cognitive inflexibility: evidence of a selective haploinsufficiency gene effect.	203
CANNABIDIOL/PHYTOCANNABINOIDS: A NEW OPPORTUNITY FOR SCHIZOPHRENIA TREATMENT?	203
Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood	201
Sex-dependent vulnerability to cannabis abuse in adolescence	197
The endocannabinoid system and psychiatric disorders.	196
SK channel modulation rescues striatal plasticity and control over habit in cannabinoid tolerance.	195
Endocannabinoids and Drug Dependence	195
Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia.	193
Cellular mechanisms underlying the interaction between cannabinoid and opioid system	192
Cannabinoids and Drugs of abuse	191
Remote memories are enhanced by COMT activity through dysregulation of the endocannabinoid system in the prefrontal cortex	190
Neurobiological mechanisms underlying cannabis-induced memory impairment	190
Cellular Mechanisms Underlying The Anxiolytic Effect Of Low Doses Of Peripheral D9-Tetrahydrocannabinol In Rats	188
The endocannabinoid system and schizophrenia: integration of evidence.	188
Lifelong imbalanced linoleic/alpha-linolenic acid intake impairs emotional and cognitive behavior in adult rats via changes in brain endocannabinoid system	184
Modulation of rat brain cannabinoid receptors after chronic morphine treatment	183
Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain	183
Endocannabinoids in the immune system and cancer	183
In vivo characterization of the specific cannabinoid receptor antagonist, SR 141716A: behavioral and cellular responses after acute and chronic treatments	182
Changes in the expression of G protein-coupled receptor kinases and beta-arrestins in mouse brain during cannabinoid tolerance - A role for Ras-ERK cascade	182
Molecular and cellular basis of cannabinoid and opioid interactions	182
Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the synthetic cannabinoid compound CP55,940	181
Sex-dependent changes in brain CB1R expression and functionality and immune CB2R expression as a consequence of maternal deprivation and adolescent cocaine exposure	181
Chronic delta 9-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates.	179
Ruolo emergente dei meccanismi epigenetici e della neuroinfiammazione nei disturbi associate al consume di cannabis	174
The psychoactive ingredient of marijuana induces behavioural sensitization	171
Ras/ERK signalling in cannabinoid tolerance: from behaviour to cellular aspects	171
Long-lasting recovery of psychotic-like symptoms in isolation-reared rats after chronic but not acute treatment with the cannabinoid antagonist AM251.	170
Cortical neuroinflammation contributes to long-term cognitive dysfunctions following adolescent delta-9-tetrahydrocannabinol treatment in female rats.	170
Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism.	169
Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems	168
Cannabinoids inhibit nitric oxide production in bone marrow derived feline macrophages	167
Termination of acute stress response by the endocannabinoid system is regulated through LSD1-mediated transcriptional repression of 2-AG hydrolases ABHD6 and MAGL	167
Estrogenic effect of procymidone through activation of MAPK in MCF-7 breast carcinoma cell line	163
Cellular mechanisms of Delta(9)-tetrahydrocannabinol behavioural sensitization	161
Studio sperimentale dell'interazione tra abuso di steroidi anabolizzanti e cannabinoidi nella depressione: dall'analisi comportamentale ai substrati cellulari	161
Presence of a reduced opioid response in interleukin-6 knock out mice	160
Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors	160
Bombesin receptor antagonist. 2. Analogues based on substance P antagonists	160
Long-term consequences of URB597 administration during adolescence on cannabinoid CB1 receptor binding in brain areas.	153
Susceptibility to Psychiatric Diseases After Cannabis Abuse in Adolescence: Animal Models	153
Cannabinoid-precipitated withdrawal: a time-course study of the behavioral aspect and its correlation with cannabinoid receptors and G protein expression.	152
Further investigations on the antipropulsive effect of centrally administered histamine and its relation with morphine.	152
Changes in rat spleen cannabinoid receptors after chronic CP-55,940: an autoradiographic study.	152
The Impact of Exposure to Cannabinoids in Adolescence: Insights from Animal Models	151
CB1 cannabinoid and mu opioid receptors density and functionality are altered in rats self-administering either heroin or the CB1 receptor agonist WIN 55,212-2	149
Behavioral, proteomic and lipidomic analyses in adult male and female rats exposed to cannabinoids during adolescence: an integrative approach to identify markers of vulnerability for psychiatric disorders and drug abuse	149
Sexually dimorphic effects of cannabinoid compounds on emotion and cognition.	149
Pertussis toxin modifies the effect of central morphine on rat intestinal motility.	149
Dos(e)Age: Role of Dose and Age in the Long-Term Effect of Cannabinoids on Cognition	148
Adolescent drug exposure: A review of evidence for the development of persistent changes in brain function	145
Is cannabinoid transmission involved in rewarding properties of drugs of abuse	143
Modulation of extracellular signal-regulated kinases cascade by cronic Delta(99-tetrahydrocannabinol treatment	143
Il sistema endocannabinoide	140
Presence of a reduced opioid response in interleukin-6 knock out mice.	137
Long-term consequences of adolescent exposure to thc-rich/cbd-poor and cbd-rich/thc-poor combinations: A comparison with pure thc treatment in female rats	137
Pregnenolone-methyl-ether enhances CLIP170 and microtubule functions improving spine maturation and hippocampal deficits related to CDKL5 deficiency	137
Immune function alterations in mice tolerant to delta9-tetrahydrocannabinol: functional and biochemical parameters.	136
The role of the endogenous cannabinoid system in drug addiction.	135
Chronic nandrolone decanoate exposure during adolescence affects emotional behavior and monoaminergic neurotransmission in adulthood	135
Pertussis toxin pretreatment affects opiate/nonopiate and stress-induced analgesia differently.	134
Totale	20.020

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	95.515
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	95.515

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	993	0	0	0	183	52	61	61	73	59	209	121	174
2022/2023	1.951	188	132	123	257	97	417	2	272	249	72	107	35
2023/2024	3.372	505	534	514	580	623	302	17	69	70	53	36	69
2024/2025	2.221	43	47	356	91	70	160	112	156	286	195	175	530
2025/2026	4.994	374	323	157	654	476	351	1.105	330	527	334	224	139
2026/2027	1.702	305	309	657	431	0	0	0	0	0	0	0	0
Totale													24.651